AAH1

AAH1 encodes an aromatic amino acid hydroxylase that produces L-DOPA and supports the Toxoplasma gondii life cycle across both host contexts (PMID:25547791, PMID:28288194). In the intermediate host, AAH1 is essential for parasite growth in nondopaminergic cells, a requirement that is independent of any effect on host dopamine, since its enzyme activity does not alter global or regional brain dopamine and its expression is negligible in tachyzoites and bradyzoites (PMID:25547791). Its predominant physiological role lies in the sexual reproductive cycle within the feline definitive host: ablation of AAH genes reduces cat infection, oocyst yield, and sporulation, consistent with a contribution to oocyst wall formation via dityrosine crosslinks (PMID:28288194). AAH1 transcription is silenced outside the sexual stages by the AP2XII-2 transcription factor, which recruits HDAC3 and MORC epigenetic machinery to the AAH1 promoter (PMID:36786611). The catalytic mechanism, substrate specificity, and structural basis of AAH1 hydroxylase activity have not been characterized in the available corpus.

1. 2014 Medium

   Establishing whether AAH1 functions merely in host dopamine manipulation or has an intrinsic parasite role, knockout genetics showed AAH1 is required for growth even in cells that lack dopamine, defining a function beyond neuromodulation.

   Evidence Knockout and complementation genetics with in vitro and in vivo growth assays in Toxoplasma gondii

   PMID:25547791

   Open questions at the time

   • The specific growth-relevant metabolite or pathway downstream of AAH1 in nondopaminergic cells was not identified
   • Single lab, single study
2. 2014 Medium

   To define the biochemical activity and physiological relevance of AAH1, enzyme and dopamine assays confirmed L-DOPA production but showed negligible tachyzoite/bradyzoite expression and no impact on host brain dopamine, decoupling AAH1 from the behavioral-manipulation hypothesis.

   Evidence Knockout/complementation genetics, dopamine measurement in vitro and in vivo, and qRT-PCR expression profiling

   PMID:25547791

   Open questions at the time

   • The stage in which AAH1 is expressed at functionally relevant levels was not resolved here
   • Substrate specificity and catalytic mechanism not characterized
3. 2017 Medium

   Cat infection experiments located AAH1's predominant role in the sexual cycle, showing that AAH ablation lowers oocyst yield and sporulation and linking L-DOPA production to oocyst wall biogenesis.

   Evidence Genetic knockout with cat infection experiments measuring oocyst yield and sporulation rates in Toxoplasma gondii

   PMID:28288194

   Open questions at the time

   • The dityrosine-crosslink contribution to oocyst wall formation was inferred rather than directly demonstrated
   • Relative contributions of AAH1 versus AAH2 not separately resolved
4. 2023 Medium

   To explain the stage-restricted expression of AAH1, chromatin profiling and genetic manipulation placed AAH1 under AP2XII-2 transcriptional repression via recruitment of HDAC3 and MORC, defining the epigenetic circuit that confines AAH1 to sexual stages.

   Evidence CUT&Tag chromatin profiling with AP2XII-2 knockdown/complementation and co-association analysis with HDAC3 and MORC in Toxoplasma gondii

   PMID:36786611

   Open questions at the time

   • Direct binding of AP2XII-2 to the AAH1 promoter versus indirect regulation not fully separated
   • The activating signal that relieves repression during sexual commitment is unknown

• The catalytic mechanism, structural basis, and cofactor requirements of AAH1 hydroxylase activity, and the direct molecular link between L-DOPA production and oocyst wall dityrosine crosslinking, remain unresolved.
• No structural model of AAH1
• No direct biochemical demonstration of dityrosine crosslink formation from AAH1-derived L-DOPA
• Growth-essential mechanism in nondopaminergic cells not defined